Chinese Pharmacopoeia Commission and European Directorate for the Quality of Medicines jointly held First Sino-Europe Pharmacopoeia and Drug Administration Seminar in Beijing on September 5-6, 2005 to deepen the understanding between China and Europe and expand cooperation. At the seminar, the drug regulatory systems of China and Europe, Chinese and European pharmacopoeias and their development systems were introduced. More than one hundred representatives, including Shao Mingli, Commissioner of the State Food and Drug Administration of China (SFDA), Dr. Agnes Artiges, Director of European Directorate for the Quality of Medicines, attended the seminar.

Chinese Pharmacopoeia was compiled based on the principle of "scientific, standard and practical" and absorbed and applied modern science and technology and research outcomes. It plays an increasing role in the international community. Since first published in 1953, it has undergone eight editions.